Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab

17Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Immunoglobulin G4 (IgG4)-releated disease is typically associated with interstitial nephritis, but rare cases of idiopathic membranous nephropathy as a renal manifestation have been described. Obinutuzumab was successfully used in refractory membranous nephropathy, but evidence for the treatment of IgG4-related disease with obinutuzumab is lacking. We report one patient's case with membranous nephropathy associated with IgG4-related disease who was treated with obinutuzumab following an anaphylactic reaction to rituximab. Obinutuzumab treatment resulted in a sustained complete remission of membranous nephropathy and a decrease of IgG4 to the normal range. This case demonstrates that membranous nephropathy associated with IgG4-related disease can be treated successfully with obinutuzumab.

Cite

CITATION STYLE

APA

Ginthör, N. E., Artinger, K., Pollheimer, M. J., Stradner, M. H., & Eller, K. (2022). Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab. Clinical Kidney Journal, 15(3), 564–566. https://doi.org/10.1093/ckj/sfab250

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free